These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27107738)

  • 1. Association of birth weight and the development of antipsychotic induced adiposity in individuals with treatment resistant schizophrenia.
    Ziauddeen H; Garcia-Rizo C; Bernardo M; Kirkpatrick B; Ozanne SE; Jones PB; Fernandez-Egea E
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):972-8. PubMed ID: 27107738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic-induced weight gain and birth weight in psychosis: A fetal programming model.
    Garriga M; Fernandez-Egea E; Mallorqui A; Serrano L; Oliveira C; Parellada E; Kirkpatrick B; Vieta E; Bernardo M; Garcia-Rizo C
    J Psychiatr Res; 2019 Aug; 115():29-35. PubMed ID: 31085376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight and metabolic changes in early psychosis-association with daily quantification of medication exposure during the first hospitalization.
    Vochoskova K; McWhinney SR; Fialova M; Kolenic M; Spaniel F; Svancer P; Boron P; Okaji Y; Trancik P; Hajek T
    Acta Psychiatr Scand; 2023 Sep; 148(3):265-276. PubMed ID: 37528692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.
    Haupt DW; Luber A; Maeda J; Melson AK; Schweiger JA; Newcomer JW
    Neuropsychopharmacology; 2005 Jan; 30(1):184-91. PubMed ID: 15367925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
    Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications.
    Tek C; Kucukgoncu S; Guloksuz S; Woods SW; Srihari VH; Annamalai A
    Early Interv Psychiatry; 2016 Jun; 10(3):193-202. PubMed ID: 25962699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agents.
    Spivak B; Musin E; Mester R; Gonen N; Talmon Y; Guy N; Roitman S; Kupchik M; Kotler M; Weizman A
    Int Clin Psychopharmacol; 1999 Jul; 14(4):229-32. PubMed ID: 10468315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in body mass index and waist-to-hip ratio in never and minimally treated patients with psychosis: A systematic review and meta-analysis.
    Shah P; Iwata Y; Caravaggio F; Plitman E; Brown EE; Kim J; Chan N; Hahn M; Remington G; Gerretsen P; Graff-Guerrero A
    Schizophr Res; 2019 Jun; 208():420-429. PubMed ID: 30685395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.
    Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP
    Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study.
    Smith RC; Maayan L; Wu R; Youssef M; Jing Z; Sershen H; Szabo V; Meyers J; Jin H; Zhao J; Davis JM
    Psychopharmacology (Berl); 2018 Dec; 235(12):3545-3558. PubMed ID: 30382354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate as an adjuvant treatment with atypical antipsychotics in schizophrenic patients experiencing weight gain.
    Ko YH; Joe SH; Jung IK; Kim SH
    Clin Neuropharmacol; 2005; 28(4):169-75. PubMed ID: 16062095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients.
    Rasmussen H; Ebdrup BH; Oranje B; Pinborg LH; Knudsen GM; Glenthøj B
    Int J Neuropsychopharmacol; 2014 Nov; 17(11):1729-36. PubMed ID: 24830305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course.
    Gebhardt S; Haberhausen M; Heinzel-Gutenbrunner M; Gebhardt N; Remschmidt H; Krieg JC; Hebebrand J; Theisen FM
    J Psychiatr Res; 2009 Mar; 43(6):620-6. PubMed ID: 19110264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood serum levels of CART peptide in patients with schizophrenia on clozapine monotherapy.
    Wysokiński A; Kłoszewska I
    Psychiatry Res; 2014 Dec; 220(1-2):170-4. PubMed ID: 25219614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate.
    Sliwa JK; Fu DJ; Bossie CA; Turkoz I; Alphs L
    BMC Psychiatry; 2014 Feb; 14():52. PubMed ID: 24559194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis.
    Siskind D; Hahn M; Correll CU; Fink-Jensen A; Russell AW; Bak N; Broberg BV; Larsen J; Ishøy PL; Vilsbøll T; Knop FK; Kisely S; Ebdrup BH
    Diabetes Obes Metab; 2019 Feb; 21(2):293-302. PubMed ID: 30187620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
    Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
    JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should obesity be a limiting factor for clozapine treatment?
    Pons i Villanueva A; Romero A; Goti J; Fernandez-Egea E; Undurraga J; Carne X; Bernardo M
    Rev Psiquiatr Salud Ment; 2013; 6(2):75-9. PubMed ID: 23084801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.